TRACK BRANDS ON AI
Monitor your brand, company, or product's online reputation in AI responses
Searching...
Loading...
It's taking longer than usual, we might be experiencing higher load.
Give it a few more seconds or try again in a moment.
Give it a few more seconds or try again in a moment.
Searching...
Loading...
What does AI know about Protagonist Therapeutics Inc ?
What does OpenAI free version (gpt-3.5-turbo) know about Protagonist Therapeutics Inc?
| Last request | 26.01.2024
(There is a high chance that below response is an AI hallucination) |
| Well Known | No |
| Description | Protagonist Therapeutics Inc is a biopharmaceutical company that focuses on the discovery and development of peptide-based drugs to treat various diseases. |
| Most Notable Achievements | Protagonist Therapeutics has a strong pipeline of potential drug candidates with promising therapeutic potential. |
| The Most Negative Fact | The company has faced challenges in successfully advancing some of its drug candidates through clinical trials. |
| Competition | None |
| Share with friends |
Register your email below to unlock features!
Don't like the AI answers? Who can help me Change them?
What does OpenAI paid version (gpt-4) know about Protagonist Therapeutics Inc?
| Request date | |
| Well Known | No |
| Description | Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company that develops peptide-based drugs to address significant unmet medical needs. |
| Most Notable Achievements | The company has a strong pipeline of novel drug candidates for various diseases. |
| The Most Negative Fact | The company is still in the clinical stage and has not yet commercialized any of its products. |
| Competition | |
| Share with friends |
What does Google AI (PaLM) know about Protagonist Therapeutics Inc?
| Last request | 26.01.2024 |
| Well Known | no |
| Description | Protagonist Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel, proprietary, small molecule therapeutics for the treatment of cancer. |
| Most Notable Achievements | The company's lead product candidate, PRT-100, is a novel, oral, small molecule inhibitor of the protein kinase B (AKT) pathway. AKT is a key regulator of cell growth, survival, and metabolism, and is overexpressed in a variety of cancers. PRT-100 has been shown to inhibit AKT in vitro and in vivo, and has demonstrated anti-tumor activity in preclinical studies. |
| The Most Negative Fact | The company has a limited product pipeline and has not yet generated any revenue. |
| Competition | None |
What does Microsoft Bing AI know about Protagonist Therapeutics Inc?
| Well Known | No |
| Description | rdydug soir sea cfcnltirhre lIomopftsestipbT e o. h i artopeeeaoaroneriiausghtuspsaio acadtdsvtv hnapate eovatummotc n- tn scdsPd itse e bucey eea npacso d i |
| Most Notable Achievements | iaortnaaiit usrodretpe utsn ootpag wc gTtnaPr t meosotodirgnuialapec hpi nanitsgsrthteedeie n tf hsepplai.l ciphi |
| The Most Negative Fact | iosnlust.cihnundoslelca colslagf n es ngfmcnnaThcogdiaeccydtufsae sed ehp i hcilgsst lcy va a etiaradr hma uir |
| Competition | oenN |
Register your email below to unlock features!
Looks like you haven't registered an account yet?
Just search for a brand, person or top-list BELOW and register your email on the search results page:
